PARP Inhibitor Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Cancer and Rising Adoption of Targeted Therapies

The PARP Inhibitor Market is estimated to be valued at US$ 887.7 Mn in 2023 and is expected to exhibit a CAGR of 32.4% over the forecast period 2023–2030, as highlighted in a new report published by Coherent Market Insights.